Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140


Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

Schein TN, Blackburn TE, Heath SL, Barnum SR.

Clin Exp Immunol. 2019 Aug 28. doi: 10.1111/cei.13366. [Epub ahead of print]


Epidemiology of lumbar punctures in hospitalized patients in the United States.

Vickers A, Donnelly JP, Moore JX, Barnum SR, Schein TN, Wang HE.

PLoS One. 2018 Dec 13;13(12):e0208622. doi: 10.1371/journal.pone.0208622. eCollection 2018.


Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.

Anderson AM, Schein TN, Kalapila A, Lai L, Waldrop-Valverde D, Moore RC, Franklin D, Letendre SL, Barnum SR.

J Neuroimmunol. 2017 Oct 15;311:35-39. doi: 10.1016/j.jneuroim.2017.07.014. Epub 2017 Jul 23.


Therapeutic Inhibition of Complement: Well Worth the Risk.

Barnum SR.

Trends Pharmacol Sci. 2017 Jun;38(6):503-505. doi: 10.1016/ Epub 2017 Apr 14.


Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia.

Stokowska A, Atkins AL, Morán J, Pekny T, Bulmer L, Pascoe MC, Barnum SR, Wetsel RA, Nilsson JA, Dragunow M, Pekna M.

Brain. 2017 Feb;140(2):353-369. doi: 10.1093/brain/aww314. Epub 2016 Dec 12.


Complement: A primer for the coming therapeutic revolution.

Barnum SR.

Pharmacol Ther. 2017 Apr;172:63-72. doi: 10.1016/j.pharmthera.2016.11.014. Epub 2016 Dec 1. Review.


Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Ramos TN, Arynchyna AA, Blackburn TE, Barnum SR, Johnston JM.

JCI Insight. 2016 Jul 7;1(10):e87919. doi: 10.1172/jci.insight.87919.


C4a: An Anaphylatoxin in Name Only.

Barnum SR.

J Innate Immun. 2015;7(4):333-9. doi: 10.1159/000371423. Epub 2015 Feb 6. Review.


Complement C5-deficient mice are protected from seizures in experimental cerebral malaria.

Buckingham SC, Ramos TN, Barnum SR.

Epilepsia. 2014 Dec;55(12):e139-42. doi: 10.1111/epi.12858. Epub 2014 Nov 10.


Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.

Gong B, Levine S, Barnum SR, Pasinetti GM.

Curr Alzheimer Res. 2014;11(7):637-44. Review.


Deletion of C-reactive protein ameliorates experimental cerebral malaria?

Szalai AJ, Barnum SR, Ramos TN.

Trans R Soc Trop Med Hyg. 2014 Sep;108(9):591-3. doi: 10.1093/trstmh/tru098. Epub 2014 Jul 7.


ICAM-1: isoforms and phenotypes.

Ramos TN, Bullard DC, Barnum SR.

J Immunol. 2014 May 15;192(10):4469-74. doi: 10.4049/jimmunol.1400135.


Experimental cerebral malaria: the murine model provides crucial insight into the role of complement.

Ramos-Summerford TN, Barnum SR.

Trends Parasitol. 2014 May;30(5):215-6. doi: 10.1016/ Epub 2014 Mar 31. No abstract available.


Membrane attack complex generation increases as a function of time in stored blood.

Hu X, Patel RP, Weinberg JA, Marques MB, Ramos TN, Barnum SR.

Transfus Med. 2014 Apr;24(2):114-6. doi: 10.1111/tme.12109. Epub 2014 Mar 4.


Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.

Bullard DC, Hu X, Crawford D, McDonald K, Ramos TN, Barnum SR.

Eur J Immunol. 2014 Apr;44(4):1194-9. doi: 10.1002/eji.201344023. Epub 2014 Feb 11.


The level of complement activation fragments is higher in red blood cell units than segments.

Hu X, Barnum SR, Patel RP, Marques MB, Weinberg JA.

Transfus Apher Sci. 2013 Dec;49(3):692-3. doi: 10.1016/j.transci.2013.10.001. Epub 2013 Oct 21. No abstract available.


The deleterious effect of red blood cell storage on microvascular response to transfusion.

Weinberg JA, MacLennan PA, Vandromme-Cusick MJ, Magnotti LJ, Kerby JD, Rue LW 3rd, Angotti JM, Garrett CA, Hendrick LE, Croce MA, Fabian TC, Barnum SR, Patel RP.

J Trauma Acute Care Surg. 2013 Nov;75(5):807-12. doi: 10.1097/TA.0b013e3182a74a9b.


The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis.

Read RW, Vogt SD, Barnum SR.

J Neuroimmunol. 2013 Nov 15;264(1-2):127-9. doi: 10.1016/j.jneuroim.2013.08.010. Epub 2013 Aug 31.


Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.

Hu X, Wetsel RA, Ramos TN, Mueller-Ortiz SL, Schoeb TR, Barnum SR.

Immunobiology. 2014 Feb;219(2):104-8. doi: 10.1016/j.imbio.2013.08.007. Epub 2013 Aug 23.


Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.

Järlestedt K, Rousset CI, Ståhlberg A, Sourkova H, Atkins AL, Thornton C, Barnum SR, Wetsel RA, Dragunow M, Pekny M, Mallard C, Hagberg H, Pekna M.

FASEB J. 2013 Sep;27(9):3797-804. doi: 10.1096/fj.13-230011. Epub 2013 Jun 4.


Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1).

Ramos TN, Bullard DC, Darley MM, McDonald K, Crawford DF, Barnum SR.

J Biol Chem. 2013 Apr 19;288(16):10962-6. doi: 10.1074/jbc.C113.457028. Epub 2013 Mar 14.


Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.

Hu X, Holers VM, Thurman JM, Schoeb TR, Ramos TN, Barnum SR.

Mol Immunol. 2013 Jul;54(3-4):302-8. doi: 10.1016/j.molimm.2012.12.018. Epub 2013 Jan 20.


ICAM-1-dependent tuning of memory CD8 T-cell responses following acute infection.

Cox MA, Barnum SR, Bullard DC, Zajac AJ.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1416-21. doi: 10.1073/pnas.1213480110. Epub 2013 Jan 7.


Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.

Hu X, Tomlinson S, Barnum SR.

Neurosci Lett. 2012 Nov 30;531(1):35-9. doi: 10.1016/j.neulet.2012.10.012. Epub 2012 Oct 16.


Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria.

Ramos TN, Bullard DC, Barnum SR.

Parasite Immunol. 2012 Nov;34(11):547-50. doi: 10.1111/pim.12002.


Erythrocyte storage increases rates of NO and nitrite scavenging: implications for transfusion-related toxicity.

Stapley R, Owusu BY, Brandon A, Cusick M, Rodriguez C, Marques MB, Kerby JD, Barnum SR, Weinberg JA, Lancaster JR Jr, Patel RP.

Biochem J. 2012 Sep 15;446(3):499-508. doi: 10.1042/BJ20120675.


Deletion of carboxypeptidase N delays onset of experimental cerebral malaria.

Darley MM, Ramos TN, Wetsel RA, Barnum SR.

Parasite Immunol. 2012 Aug-Sep;34(8-9):444-7. doi: 10.1111/j.1365-3024.2012.01376.x.


The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Ramos TN, Darley MM, Weckbach S, Stahel PF, Tomlinson S, Barnum SR.

J Biol Chem. 2012 Jul 13;287(29):24734-8. doi: 10.1074/jbc.C112.378364. Epub 2012 Jun 11.


Microvascular response to red blood cell transfusion in trauma patients.

Weinberg JA, MacLennan PA, Vandromme-Cusick MJ, Angotti JM, Magnotti LJ, Kerby JD, Rue LW 3rd, Barnum SR, Patel RP.

Shock. 2012 Mar;37(3):276-81. doi: 10.1097/SHK.0b013e318241b739.


Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis.

Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW, Zwinderman AH, Morgan BP, Barnum SR, van der Ende A, Koedel U, van de Beek D.

J Clin Invest. 2011 Oct;121(10):3943-53. doi: 10.1172/JCI57522. Epub 2011 Sep 19.


Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.

Ramos TN, Darley MM, Hu X, Billker O, Rayner JC, Ahras M, Wohler JE, Barnum SR.

J Immunol. 2011 Jun 15;186(12):6657-60. doi: 10.4049/jimmunol.1100603. Epub 2011 May 13.


Red blood cell age and potentiation of transfusion-related pathology in trauma patients.

Weinberg JA, Barnum SR, Patel RP.

Transfusion. 2011 Apr;51(4):867-73. doi: 10.1111/j.1537-2995.2011.03098.x.


Evolution and variation of the nifD and hupL elements in the heterocystous cyanobacteria.

Henson BJ, Hartman L, Watson LE, Barnum SR.

Int J Syst Evol Microbiol. 2011 Dec;61(Pt 12):2938-49. doi: 10.1099/ijs.0.028340-0. Epub 2011 Jan 29.


Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

Hu XZ, Wright TT, Jones NR, Ramos TN, Skibinski GA, McCrory MA, Barnum SR, Szalai AJ.

Autoimmune Dis. 2010 Oct 12;2011:484936. doi: 10.4061/2011/484936.


CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.

Ingersoll SA, Martin CB, Barnum SR, Martin BK.

Mol Immunol. 2010 Nov-Dec;48(1-3):219-30. doi: 10.1016/j.molimm.2010.08.007. Epub 2010 Sep 1.


Inferring the evolutionary history of Mo-dependent nitrogen fixation from phylogenetic studies of nifK and nifDK.

Hartmann LS, Barnum SR.

J Mol Evol. 2010 Jul;71(1):70-85. doi: 10.1007/s00239-010-9365-8. Epub 2010 Jul 17.


Murine cerebral malaria: the whole story.

Hunt NH, Grau GE, Engwerda C, Barnum SR, van der Heyde H, Hansen DS, Schofield L, Golenser J.

Trends Parasitol. 2010 Jun;26(6):272-4. doi: 10.1016/ Epub 2010 Apr 8. No abstract available.


Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis.

Hu X, Barnum SR, Wohler JE, Schoeb TR, Bullard DC.

Mol Immunol. 2010 May;47(9):1692-1700. doi: 10.1016/j.molimm.2010.03.005. Epub 2010 Apr 3.


beta2-integrins in demyelinating disease: not adhering to the paradigm.

Hu X, Wohler JE, Dugger KJ, Barnum SR.

J Leukoc Biol. 2010 Mar;87(3):397-403. doi: 10.1189/jlb.1009654. Epub 2009 Dec 9. Review.


Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.

Ramos TN, Wohler JE, Barnum SR.

Neurosci Lett. 2009 Dec 31;467(3):234-6. doi: 10.1016/j.neulet.2009.10.045. Epub 2009 Oct 20.


gammadelta T cells: the overlooked T-cell subset in demyelinating disease.

Wohler JE, Smith SS, Barnum SR.

J Neurosci Res. 2010 Jan;88(1):1-6. doi: 10.1002/jnr.22176. Review.


Gammadelta T cells in EAE: early trafficking events and cytokine requirements.

Wohler JE, Smith SS, Zinn KR, Bullard DC, Barnum SR.

Eur J Immunol. 2009 Jun;39(6):1516-26. doi: 10.1002/eji.200839176.


Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR.

J Immunol. 2009 Mar 1;182(5):2628-40. doi: 10.4049/jimmunol.0802954.


Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.

Osmers I, Smith SS, Parks BW, Yu S, Srivastava R, Wohler JE, Barnum SR, Kabarowski JH.

J Neuroimmunol. 2009 Feb 15;207(1-2):18-23. doi: 10.1016/j.jneuroim.2008.11.008. Epub 2009 Jan 9.


Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.

Dugger KJ, Zinn KR, Weaver C, Bullard DC, Barnum SR.

J Neuroimmunol. 2009 Jan 3;206(1-2):22-7. doi: 10.1016/j.jneuroim.2008.10.006. Epub 2008 Nov 17.


Nylon wool purification alters the activation of T cells.

Wohler JE, Barnum SR.

Mol Immunol. 2009 Feb;46(5):1007-10. doi: 10.1016/j.molimm.2008.09.017. Epub 2008 Oct 25.


The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ.

J Neurochem. 2008 Dec;107(5):1169-87. doi: 10.1111/j.1471-4159.2008.05668.x. Epub 2008 Oct 24. Review.


Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice.

Smith SS, Ludwig M, Wohler JE, Bullard DC, Szalai AJ, Barnum SR.

Neurosci Lett. 2008 Sep 12;442(2):158-60. doi: 10.1016/j.neulet.2008.07.005. Epub 2008 Jul 6.


Excision of the nifD element in the heterocystous cyanobacteria.

Henson BJ, Pennington LE, Watson LE, Barnum SR.

Arch Microbiol. 2008 Apr;189(4):357-66. doi: 10.1007/s00203-007-0326-6. Epub 2008 Feb 19.


Supplemental Content

Loading ...
Support Center